Immunohistochemical expression of PRAME is a marker of poor prognosis in uveal melanoma: A clinico-pathologic and immunohistochemical study on a series of 85 cases-Reference-Cited by-同舟云学术

Immunohistochemical expression of PRAME is a marker of poor prognosis in uveal melanoma: A clinico-pathologic and immunohistochemical study on a series of 85 cases

Published:2023-07 Issue: Volume:247 Page:154543
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Broggi Giuseppe^ORCID,Failla Maria,Russo Andrea,Longo Antonio,Palicelli Andrea,Zanelli Magda,Lombardo Claudia,Loreto Carla,Merolla Francesco,Di Crescenzo Rosa Maria,Ilardi Gennaro,Varricchio Silvia,Staibano Stefania,Caltabiano Rosario

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference30 articles.

1. Uveal melanoma;Spagnolo;Cancer Treat. Rev.,2012

2. Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part II: treatment indications and complications;Foti;Insights Imaging,2021

3. Immunohistochemical expression of ABCB5 as a potential prognostic factor in uveal melanoma;Broggi;Appl. Sci.,2019

4. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications;Correa;Graefes Arch. Clin. Exp. Ophthalmol.,2014

5. Prognostic biomarkers in uveal melanoma: the status quo, recent advances and future directions;Lamas;Cancers (Basel),2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal Melanoma: Review from a Pathologist Point of View;Clinics in Dermatology;2024-09

2. BAUSSS biomarker improves melanoma survival risk assessment;Journal of the European Academy of Dermatology and Venereology;2024-08-31

3. A cuproptosis-related prognostic signature for guiding clinical diagnosis and treatment in uveal melanoma patients;Heliyon;2024-08

4. Expression of Immunotherapy Target PRAME in Cancer Correlates with Histone H3 Acetylation and Is Unrelated to Expression of Methylating (DMNT3A/3B) and Demethylating (TET1) Enzymes;Journal of Clinical Medicine;2024-03-08

5. PRAME Updated: Diagnostic, Prognostic, and Therapeutic Role in Skin Cancer;International Journal of Molecular Sciences;2024-01-27